Cannabidiol is without a doubt one of the most popular natural medicines at the moment. Extracted from hemp, a variety of cannabis with less than 0.3% THC, this chemical has held the world in thrall for the past year or two. Early trials to prove its medicinal properties found that the hemp extract did, in fact, have therapeutic abilities, and its popularity has soared ever since.
At the moment, the market is filled with thousands of cannabidiol-infused products, from tinctures and vapes to topicals and nasal sprays. Currently worth millions of dollars in sales, experts predict that it will hit $20 billion by 2024. Despite these extremely attractive…
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire is part of the InvestorBrandNetwork.